Edwards Lifesciences Corp (EW) stock
EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3057% above fair value
$105.80−0.01 (-0.01%)
Close on Nov 12, 2026Market cap $60.98BP/E 59.8Yield –
Edwards Lifesciences statistics
107 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 9, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 7.87
- 4.85
- P/OCF Ratio
- 35.52
- 22.12
Enterprise valuationIndustry
- EV / Sales
- 8.55
- 2.70
- EV / EBIT
- 39.58
- 24.04
- EV / FCF
- 40.05
- 27.78
Share statisticsIndustry
- Shares Change (YoY)
- -1.47%
- 3.22%
- Shares Change (QoQ)
- -0.17%
- 0.16%
- Float
- 575M
- 37M
- Shares Held by Insiders
- 0.22%
- 10.5%
- Shares Held by Institutions
- 91.0%
- 60.2%
Short sellingIndustry
- Short Interest
- 9M
- –
- Short Interest Change
- 0.52%
- -2.57%
- Short % of Float
- 1.63%
- 5.12%
- Short % of Shares Outstanding
- 1.63%
- 3.98%
- Days to Cover
- 2.80
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $106.80
- –
- 52-Week Low
- $74.66
- –
- 20-Day Moving Average
- $95.02
- –
- 50-Day Moving Average
- $90.08
- –
- 200-Day Moving Average
- $86.21
- –
- Average True Range (14)
- $2.93
- –
- Price Change (1 Week)
- 4.94%
- 2.01%
- Price Change (1 Month)
- 22.4%
- -0.57%
- Price Change (3 Months)
- 15.5%
- -7.91%
- Price Change (6 Months)
- 30.1%
- -0.90%
- Price Change (YTD)
- 24.1%
- -0.82%
- Price Change (1 Year)
- 24.2%
- -1.18%
- Price Change (3 Years)
- 63.8%
- 6.56%
- Price Change (5 Years)
- -8.79%
- -49.8%
- Price Change (10 Years)
- 248.8%
- 57.3%
- Average Volume (10 Days)
- 7M
- –
- Average Volume (20 Days)
- 5M
- –
- Average Volume (90 Days)
- 4M
- –
- Relative Volume
- 1.03
- 0.82
- Relative Strength Index (14)
- 78.8
- 47.7
- Volatility (1 Year)
- 25.5%
- 64.2%
- Beta (5 Years)
- 0.97
- 1.05
MarginsIndustry
- Pretax Margin
- 21.5%
- -2.55%
- EBITDA Margin
- 24.2%
- -2.82%
- FCF Margin
- 21.3%
- 0.40%
Returns on capitalIndustry
- Return on Equity (ROE)
- 9.70%
- -17.1%
- Return on Assets (ROA)
- 7.45%
- -12.2%
- Return on Invested Capital (ROIC)
- 14.4%
- -3.22%
- Return on Capital Employed (ROCE)
- 11.5%
- -8.13%
Financial positionIndustry
- Current Ratio
- 4.60
- 2.45
- Quick Ratio
- 3.44
- 1.53
- Debt / Equity
- 0.06
- 0.42
- Debt / EBITDA
- 0.37
- 2.19
- Debt / FCF
- 0.42
- 3.62
- Net Debt / EBITDA
- -2.51
- 1.53
GrowthIndustry
- Revenue Growth (YoY)
- 13.4%
- 9.24%
- Net Income Growth (YoY)
- -25.3%
- 13.4%
- EPS Growth (YoY)
- -23.7%
- 15.1%
- FCF Growth (YoY)
- 77.1%
- 7.64%
- Revenue Growth (3Y CAGR)
- 10.8%
- 7.08%
- Revenue Growth (5Y CAGR)
- 6.70%
- 11.8%
- EPS Growth (3Y CAGR)
- -9.14%
- 3.11%
- EPS Growth (5Y CAGR)
- 7.08%
- 7.64%
EfficiencyIndustry
- Asset Turnover
- 0.49
- 0.59
- Inventory Turnover
- 1.28
- 2.20
- Revenue Per Employee
- $417.17K
- $330.60K
- Profits Per Employee
- $63.83K
- -$41.39K
- Employee Count
- 16,000
- 186
- WACC
- 9.66%
- 9.71%
Income statement (TTM)Industry
- Pretax Income
- $1.43B
- -$1.69M
Balance sheetIndustry
- Net Cash (Debt)
- $4.05B
- $3.73M
- Net Cash Per Share
- $7.02
- $0.24
- Equity (Book Value)
- $10.86B
- $63.44M
- Book Value Per Share
- $18.84
- $3.26
- Tangible Book Value
- $7.75B
- $11.04M
- Working Capital
- $5.67B
- $56.85M
Cash flow (TTM)Industry
- Capital Expenditures
- -$292.80M
- -$3.69M
- FCF Per Share
- $2.47
- -$0.01
Dividends and yieldsIndustry
- Earnings Yield
- 1.67%
- -4.70%
- FCF Yield
- 2.34%
- 0.24%
- Buyback Yield
- 1.24%
- 0.79%
- Shareholder Yield
- 1.24%
- 1.05%
Taxes and interestIndustry
- Income Tax
- $444.70M
- $1.63M
- Effective Tax Rate
- 31.0%
- 18.3%
Scores and fair valueIndustry
- Graham Number
- $27.39
- $38.11
- Graham Upside
- -74.1%
- -56.3%
- Altman Z-Score
- 14.29
- 2.44
- Piotroski F-Score
- 5
- 5
- Beneish M-Score
- -2.62
- -2.64
- Lynch Fair Value
- $12.53
- –
- Lynch Upside
- -88.2%
- -45.1%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | EW | S&P 500 | Difference | EW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +22.5% | -2.7% | +25.2 pts | ||
| 3 months | +13.7% | -1.7% | +15.4 pts | ||
| Year to date | +24.1% | +11.9% | +12.2 pts | ||
| 1 year | +23.6% | +12.0% | +11.6 pts | ||
| 3 years | +64.8% | +78.2% | −13.4 pts | +18.1% | +21.2% |
| 5 years | -8.8% | +73.2% | −82.0 pts | -1.8% | +11.6% |
| 10 years | +248.8% | +309.6% | −60.9 pts | +13.3% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
9M EW shares were sold short on Oct 30, 2026, up 0.5% from the previous report, or 1.63% of the shares available to trade. At recent volumes it would take 2.8 days to buy them back. Over the last 20 sessions, 44.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 9,382,239 | +0.5% | 3,346,352 | 2.8 |
| Oct 15, 2026 | 9,333,399 | -2.2% | 3,799,839 | 2.5 |
| Sep 30, 2026 | 9,538,735 | +5.0% | 3,875,387 | 2.5 |
| Sep 15, 2026 | 9,088,401 | +0.7% | 2,880,751 | 3.1 |
| Aug 31, 2026 | 9,022,064 | -11.9% | 2,810,336 | 3.2 |
| Aug 14, 2026 | 10,241,231 | +2.0% | 3,263,390 | 3.1 |
| Jul 31, 2026 | 10,043,721 | -11.5% | 5,683,561 | 1.8 |
| Jul 15, 2026 | 11,352,019 | -1.0% | 4,522,301 | 2.5 |
| Jun 30, 2026 | 11,466,764 | -2.8% | 5,443,863 | 2.1 |
| Jun 15, 2026 | 11,797,466 | -3.0% | 4,914,670 | 2.4 |
| May 29, 2026 | 12,163,159 | +6.7% | 5,235,630 | 2.3 |
| May 15, 2026 | 11,394,337 | +8.1% | 4,480,101 | 2.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?